← Back to Search

N/A

Single Leg Immobilization for Muscle Atrophy

N/A
Recruiting
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 7 days
Awards & highlights

Study Summary

This trial will help researchers understand if there are differences in how men and women's bodies react to muscle atrophy.

Eligible Conditions
  • Muscle Atrophy
  • Muscle Wasting

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fractional muscle protein synthesis rate
Secondary outcome measures
Muscle size
Muscle strength
Protein abundance and phosphorylation
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Single Leg Immobilization - MalesExperimental Treatment1 Intervention
Males will be subjected to 7-days of single-leg immobilization.
Group II: Single Leg Immobilization - FemalesExperimental Treatment1 Intervention
Females will be subjected to 7-days of single-leg immobilization.

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
399 Previous Clinical Trials
1,000,258 Total Patients Enrolled

Media Library

Single Leg Immobilization (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT05314413 — N/A
Muscle Atrophy Research Study Groups: Single Leg Immobilization - Males, Single Leg Immobilization - Females
Muscle Atrophy Clinical Trial 2023: Single Leg Immobilization Highlights & Side Effects. Trial Name: NCT05314413 — N/A
Single Leg Immobilization (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05314413 — N/A
~12 spots leftby Jun 2025